Specialist for Hematology and Medical Oncology at Charité Universitaetsmedizin Berlin
Berlin, Deutschland
Joined February 2018
- Tweets148
- Following82
- Followers253
- Likes40
Finally out!
The Basis for Future Personalized Therapy Approaches - Machine Learning-Generated 1-Year Survival Rate, Metastatic Status and Therapy-dependent Survival in Pancreatic Cancer Patients - European Journal of Cancer ejcancer.com/article/S0959-8…
Lieber Herr Nörenberg, herzlichen Glückwunsch! Q
🎖️Gratulation an Dr. Daniel Nörenberg! Der #CharitéBerlin-Onkologe wurde von der German Lymphoma Alliance für seine Arbeit zu primären mediastinalen B-Zell-Lymphomen ausgezeichnet – eine Krebserkrankung, die v.a. junge Frauen betrifft. charite.de/forschung/ausgeze…
ALT © Kristin Schmidt/GLA
Sebastian Stintzing retweeted
🎖️Gratulation an Dr. Daniel Nörenberg! Der #CharitéBerlin-Onkologe wurde von der German Lymphoma Alliance für seine Arbeit zu primären mediastinalen B-Zell-Lymphomen ausgezeichnet – eine Krebserkrankung, die v.a. junge Frauen betrifft. charite.de/forschung/ausgeze…
ALT © Kristin Schmidt/GLA
Baseline Liquid Biopsy in Relation to Tissue-Based Parameters in Metastatic Colorectal Cancer: Results From the Randomized FIRE-4 (AIO-KRK-0114) Study | Journal of Clinical Oncology ascopubs.org/doi/10.1200/JCO…
Sebastian Stintzing retweeted
The SAGITTARIUS clinical trial will use personalised liquid biopsy tests to personalise the management & therapy of patients with high-risk stage II or operable stage III colon cancer. It will include 4 experimental arms.
More: sagittarius-horizon.eu/
Sebastian Stintzing retweeted
🎉 The SAGITTARIUS trial first patient is now enrolled!
This marks a significant milestone in this project, which aims to revolutionise colon cancer treatment.
Find out more and stay tuned for updates: sagittarius-horizon.eu/ 🌐
#CRC #EUCancerMission #SagittariusEU
Sebastian Stintzing retweeted
Outstanding presentation by @JenSeligmann at #ESMOGI24 about neoadj strategies to modify the status quo in localized colon cancer. Academic research will be the key, sure! 💪🏻 @myESMO #ESMOAmbassadors
Sebastian Stintzing retweeted
🔊On this #WorldDigestiveHealthDay, let's make digestive health a priority!
The #SAGITTARIUSproject is exploring liquid biopsy to detect colon cancer signs post-surgery. This personalized approach aims to enhance post-surgical treatment compared to standard methods.✨
Sebastian Stintzing retweeted
Nothing to add here…
@Prof_Nadia_H is a huge role model and will an amazing @myESMO president!
Vote now ‼️
esmo.org/about-esmo/how-we-w…
Dear Friends
I wholeheartedly Support Prof. Nadia Harbeck🇩🇪 @Prof_Nadia_H for President of @myESMO 2027-2028
✅Strong Advocate for Women in Oncology
✅Focus on future Generations
✅Vision of Inclusion and Diversity
✅ESMO Lifetime Achievement Award
Link
esmo.org/about-esmo/how-we-w…
authors.elsevier.com/c/1iiO6…
Finally out! Thanks to all the co-authors and the medical writer team!
Sebastian Stintzing retweeted
Tomorrow the @OncoAlert 🚨 Newsletter will be out!
There are some really 🔥 news, so if you don’t receive it yet, there is still time to sign up!
Especially important in my opinion are the @ASCO guidelines on drug shortages in #oncology ‼️
The @OncoAlert 🚨Newsletter
OUT TOMORROW November 16, 2023
REGISTER AT: OncoAlert360.com
Covering:
✅🔑🫁🌊KEYNOTE 564 in#RCC
✅PACIFIC2 in #NSCLC
✅TALAPRO2 EMA recommendation of Talazoparib + Enzalutamide
✅Drug Shortages in Oncology: @ASCO
✅Clinical Guidance Lessons from ADAURA📷 by
@JackWestMD @n8pennell
✅Severe Immune-Related Enteritis after In Utero Exposure to Pembrolizumab and more
@ChristianRolfo @GlopesMd @StephenVLiu
@bmassutis @Tony_Calles @s_couraud
@CharuAggarwalMD @christine_lovly @jillfeldman4
@ivybelkins @bensolomon1 @VanitaNoronha
@DrSanjayPopat @JulienMazieres @TerriConneran @montypal @crisbergerot @DrDanielHeng
@apolo_andrea @DrChoueiri @PGrivasMDPhD
@TiansterZhang @HHammersMD @ravikanesvaran
@neerajaiims @amerseburger @sonpavde
@drenriquegrande @scserendipity1 @tompowles1
@DrYukselUrun @JournalCancer
#OncoAlertAF
@nataliagandur @acampsmalea @MartaPerachino
@heinrich_kat @yekeduz_emre @HHorinouchi @FadiHaddad_MD @Dr_Ivanoncologo
@DrYukselUrun @FuenteApolo @Abdallah81MD
FIRE 🔥 Treffen im Rahmen des @AIO_Onkologie Herbstkongress! @ArndtStahler @heinrich_kat @BenWestphalen
Studien für Patienten von Klinikern! Die Therapie optimieren!
AIO Herbstkongress ist gestartet! YMO Sprecherin @heinrich_kat stellt die Aktivitäten der YMO der AIO vor! @AIO_Onkologie
Sebastian Stintzing retweeted
Today, we were at SAGITTARIUS kick-off meeting in Milan 🇮🇹! Our role in the project is to represent the patient's perspective in the clinical trial's design & execution. Additionally, we'll ensure effective communication & dissemination to maximise project impact. #SagittariusEU
Welcome to the SAGITTARIUS kick-off meeting! SAGITTARIUS is an international research project aimed at optimising clinical management of locoregional stage II high-risk/stage III colon cancer through an innovative precision medicine approach.
#SagittariusEU #eucanbeatcancer
Sebastian Stintzing retweeted
Welcome to the SAGITTARIUS kick-off meeting! SAGITTARIUS is an international research project aimed at optimising clinical management of locoregional stage II high-risk/stage III colon cancer through an innovative precision medicine approach.
#SagittariusEU #eucanbeatcancer
Sebastian Stintzing retweeted
Save the date for the ESMO Gastrointestinal Cancers Congress 2024, on 26-29 June, in Munich, Germany. Be ready to share your latest studies on effectively implementing recent discoveries to improve the lives of patients w/ #GIcancers. ow.ly/mzLz50PPwT0 #ESMOGI24 @DucreuxMichel @MacarullaTeresa